KELSEY CARTER: Open Payments
NPI 1215539507 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 30 payments from 14 companies in 2025. Trend: 2023 $853 · 2024 $877 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $118 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Medtronic, Inc. | 1 | $56 |
| Novo Nordisk Inc | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| PFIZER INC. | 2 | $36 |
Products named: SUBLOCADE, AIRSUPRA, CAPLYTA, INTELLIS ADAPTIVESTIM, LEQVIO, Tlando, NEXLETOL, JARDIANCE.
Industry payments across FL — which companies pay providers there.
